Letrozole Induced Hypercalcemia in a Patient with Breast Cancer
Hypersecretion of PTHrP is a relatively common cause of malignancy-related hypercalcemia. However, there is only one case report of letrozole induced hypercalcemia. A 52-year-old female patient was referred to our clinic because of the recent discovery of hypercalcemia (11.0 mg/dL). The patient had...
Saved in:
| Main Authors: | Suleyman Hilmi Ipekci, Suleyman Baldane, Ercument Ozturk, Murat Araz, Huseyin Korkmaz, Fatih Colkesen, Levent Kebapcilar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2014/608585 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical insight into hypercalcemia in children
by: Huseyin Anıl Korkmaz
Published: (2025-08-01) -
Angioneurotic edema of metastatic breast cancer patient associated with letrozole
by: Yasemin Bakkal Temi, et al.
Published: (2017-12-01) -
Abemaciclib and Letrozole in Metastatic Male Breast Cancer
by: Leon Schönfeld, et al.
Published: (2024-11-01) -
Letrozole and palbociclib in advanced breast cancer: Outcome from cancer institute, Chennai
by: Vijay Gnanaguru, et al.
Published: (2020-01-01) -
Prolonged Hypercalcemia-Induced Psychosis
by: Lauren Nagy, et al.
Published: (2020-01-01)